Antiphospholipid syndrome (APS) is an autoimmune disease characterized by antiphospholipid antibodies and thrombotic events. The kidney is a major target organ of APS, which is often present in association with other autoimmune disorders. In this Review, Sciascia et al. discuss the broadening spectrum of renal events associated with APS and the different therapeutic approaches that might be required for effective treatment.
- Savino Sciascia
- Maria José Cuadrado
- Dario Roccatello
